Jump to content


Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Clinical Risk Assessment Of Organ Manifestations In Systemic Sclerosis


  • Please log in to reply
No replies to this topic

#1 Guest_Sherrill_*

Guest_Sherrill_*
  • Guests

Posted 10 April 2007 - 08:13 PM

Clinical risk assessment of organ manifestations in systemic sclerosis - a report from the EULAR Scleroderma Trials And Research (EUSTAR) group data base. Diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subsets are associated with particular organ manifestations, but in this analysis the clinical distinction appeared superseded by an antibody based classification in predicting some scleroderma complications. PubMed. Ann rheumatologist Dis. 2007 Feb 1. (Also see: Types of Scleroderma and Antibodies)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information. http://www.sclero.org/news/a-to-z.html